Net Loss per Share (Tables)

3 Months Ended

Mar. 31, 2023

Net Loss per Share

Summary of Outstanding Potentially Dilutive Common Stock Equivalents have been Excluded from the Calculation of Diluted Net Loss Per Share

The following outstanding potentially dilutive common stock equivalents have been excluded from the calculation of diluted net loss per share for the periods presented due to their antidilutive effect:

	Three Months Ended
	March 31,
	2023		2022
Warrants to purchase common stock		1,272,680		272,680
Common stock options issued and outstanding		1,223,850		1,050,969
Total		2,496,530		1,323,649